Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000193660 | SCV000247707 | benign | not specified | 2017-08-04 | criteria provided, single submitter | clinical testing | |
Center for Pediatric Genomic Medicine, |
RCV000224826 | SCV000280841 | benign | not provided | 2016-04-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000224826 | SCV000653829 | benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000224826 | SCV000842564 | benign | not provided | 2018-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002460969 | SCV000846938 | benign | Inborn genetic diseases | 2016-06-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000224826 | SCV001892260 | benign | not provided | 2019-09-17 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000224826 | SCV001740381 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000193660 | SCV001926711 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000224826 | SCV001971250 | likely benign | not provided | no assertion criteria provided | clinical testing |